Wave Life Sciences Ltd. Ordinary Shares (WVE) is a publicly traded Healthcare sector company. As of July 23, 2026, WVE trades at $5.69 with a market cap of $1.11B and a P/E ratio of -5.42. WVE moved -0.87% today. Year to date, WVE is -66.24%; over the trailing twelve months it is -27.62%. Its 52-week range spans $5.02 to $21.73. Analyst consensus is strong buy with an average price target of $23.75. Rallies surfaces WVE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for WVE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.69 |
| Market Cap | $1.11B |
| P/E Ratio | -5.42 |
| EPS | $-1.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.73 |
| 52-Week Low | $5.02 |
| Volume | 399.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $71.80M |
| Net Income | $-183.59M |
| Gross Margin | 0.00% |
13 analysts cover WVE: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $23.75.